Texas Children's Hospital

By Jonah Comstock November 21, 2017
Brisbane, Australia-based ResApp intended to have its software, which uses a smartphone microphone to diagnose respiratory conditions based on coughs, well on its way through the FDA by now. But this past summer, the company’s big plans hit a major setback when the data came back from its landmark clinical trial, conducted at such austere institutions as Massachusetts General Hospital, Cleveland...
By Jonah Comstock August 9, 2017
Brisbane, Australia-based digital health company ResApp has been talking up its Smartcough-C study — a multisite, double-blind study of the company’s smartphone-based respiratory analysis software — for a number of months. Conducted at Massachusetts General Hospital, Cleveland Clinic, and Texas Children’s Hospital, the trial was intended to support ResApp’s FDA submission for a number of...
By Jonah Comstock November 16, 2016
ResApp has announced the final site and received the final IRB approval for its Smartcough-C trial. Texas Children's Hospital will join the previously announced Massachusetts General Hospital and Cleveland Clinic in a three-site trial of the Australian company's ResAppDx app, which essentially uses the smartphone microphone as a stethoscope to listen to a patient’s breathing. The double-blind...